
Tokiner®
Ponatinib
Therapeutic action
Protein kinase inhibitor. Antineoplastic and immunomodulatory agent
Indications
Chronic Myeloid Leukemia / Acute Lymphoblastic Leukemia
Presentation
Coated tablets of 15 mg and 45 mg
Protein kinase inhibitor. Antineoplastic and immunomodulatory agent
Chronic Myeloid Leukemia / Acute Lymphoblastic Leukemia